Industry News
Washington University Researchers Show Biovica's DiviTum Can Evaluate Ibrance Efficacy After Just Two Weeks Biovica's
New biomarker evaluates the biologic activity of blockbuster breast cancer drug Ibrance
New biomarker evaluates the biologic activity of blockbuster breast cancer drug Ibrance